Cancer Stem Cells: Challenges and Opportunities

In this webinar, our panelist will discuss emerging tools and strategies for the characterization of stem cells derived from heterogeneous populations and applications of this model system for drug discovery.

Written byThe Scientist Marketing Team
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Cancer stem cells represent an attractive model for in vitro tumor modeling, especially for closer, physiological screening of new anticancer compounds. Although much progress has been made in culturing cancer stem cells, technical challenges persist in the identification and characterization of cell types in a heterogeneous cellular population. In this webinar, our panelist will discuss emerging tools and strategies for the characterization of stem cells derived from heterogeneous populations and applications of this model system for drug discovery. Following the presentation, attendees will have an opportunity to ask questions concerning their specific applications and receive answers in real-time.

Topics to be covered:

Dr. Christian D. Muller
Faculty Member
Faculté de Pharmacie
Université de Strasbourg

Protein Simple

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
Share
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Screening 3D Brain Cell Cultures for Drug Discovery

Screening 3D Brain Cell Cultures for Drug Discovery

Explore synthetic DNA’s many applications in cancer research

Weaving the Fabric of Cancer Research with Synthetic DNA

Twist Bio 
Illustrated plasmids in bright fluorescent colors

Enhancing Elution of Plasmid DNA

cytiva logo
An illustration of green lentiviral particles.

Maximizing Lentivirus Recovery

cytiva logo

Products

The Scientist Placeholder Image

Sino Biological Sets New Industry Standard with ProPure Endotoxin-Free Proteins made in the USA

sartorius-logo

Introducing the iQue 5 HTS Platform: Empowering Scientists  with Unbeatable Speed and Flexibility for High Throughput Screening by Cytometry

parse_logo

Vanderbilt Selects Parse Biosciences GigaLab to Generate Atlas of Early Neutralizing Antibodies to Measles, Mumps, and Rubella

shiftbioscience

Shift Bioscience proposes improved ranking system for virtual cell models to accelerate gene target discovery